Sofosbuvir-based regimens for HCV in stage 4–stage 5 chronic kidney disease. A systematic review with meta-analysis Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Ezequiel Ridruejo

The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Piergiorgio Messa

Successful treatment of chronic hepatitis C in a kidney transplant patient with only 2 weeks of direct-acting antiviral therapy Sofia de Sá Guimarães Cerqueira, Mónica Dinis Mesquita, Rui Arlindo Castro, Paulo Carrola, Teresa Margarida Pinto Ribeiro Morgado, Paula Marques